China Jo-Jo Drugstores Grants Stock Awards
Ticker: RDGT · Form: 6-K · Filed: Apr 16, 2024 · CIK: 1856084
| Field | Detail |
|---|---|
| Company | China Jo-Jo Drugstores, Inc. (RDGT) |
| Form Type | 6-K |
| Filed Date | Apr 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: stock-awards, equity-incentive-plan, compensation
TL;DR
Jo-Jo Drugstores just dropped some stock awards, could mean dilution.
AI Summary
China Jo-Jo Drugstores, Inc. announced on April 16, 2024, the grant of restricted stock awards under the Company's 2023 Equity Incentive Plan. The filing does not specify the number of shares or the recipients of these awards.
Why It Matters
This filing indicates potential future equity dilution or executive compensation adjustments, which could impact shareholder value.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of stock awards and does not contain significant financial or operational news.
Key Players & Entities
- China Jo-Jo Drugstores, Inc. (company) — Registrant
- 2023 Equity Incentive Plan (plan) — Plan under which awards were granted
FAQ
What is the total number of restricted stock awards granted?
The filing does not specify the total number of restricted stock awards granted.
Who are the recipients of the restricted stock awards?
The filing does not disclose the specific recipients of the restricted stock awards.
What is the vesting schedule for these restricted stock awards?
The filing does not provide details on the vesting schedule for the granted awards.
What is the grant date of these restricted stock awards?
The filing indicates the grant of awards occurred in April 2024, but a specific grant date is not provided.
What is the purpose of granting these restricted stock awards?
The purpose is to incentivize and retain key employees and directors, as per the 2023 Equity Incentive Plan.
Filing Stats: 265 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-04-16 16:30:11
Filing Documents
- ea0204000-6k_chinajojo.htm (6-K) — 8KB
- 0001213900-24-033459.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 16, 2024 CHINA JO-JO DRUGSTORES, INC. By: /s/ Lei Liu Name: Lei Liu Title: Chief Executive Officer 2